Profile data is unavailable for this security.
About the company
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).
- Revenue in USD (TTM)87.70bn
- Net income in USD14.77bn
- Incorporated1887
- Employees131.90k
- LocationJohnson & JohnsonOne Johnson & Johnson PlazaNEW BRUNSWICK 08933United StatesUSA
- Phone+1 (732) 524-2455
- Fax+1 (732) 214-0332
- Websitehttps://www.jnj.com/
Mergers & acquisitions
| Acquired company | JNJ:NYQ since announced | Transaction value |
|---|---|---|
| V-Wave Ltd | -4.08% | 1.70bn |
| Shockwave Medical Inc | 0.41% | 14.07bn |
| Ambrx Biopharma Inc | -4.97% | 1.98bn |
